Louisiana is set to receive a substantial financial injection as part of a multi-billion dollar settlement with Purdue Pharma and the Sackler family, as reported by WWLTV. The agreement, which encompasses all 55 U.S. states and territories, results in nearly $70 million for the state over the next 15 years. The funds are earmarked to bolster the fight against the opioid crisis, a scourge that has deeply scarred communities across the nation.
In a statement obtained by WWLTV, Attorney General Liz Murrill expressed her office's commitment to accountability. “My office will continue to hold these opioid companies’ feet to the fire,” said Murrill. The majority of Louisiana's share, which totals $69,795,302, is slotted for distribution within the first three years of the settlement's timeline to address addiction treatment, prevention, and recovery programs.
According to coverage by WGNO, the settlement funds will be channeled through the Opioid Abatement Trust and then distributed to parishes throughout Louisiana. The deal additionally concludes the Sacklers’ involvement with Purdue Pharma and obstructs their capability to sell opioids within the United States, marking a significant turn in the battle against opioid addiction.
Brian Mann of NPR, reporting for PBS’s Newshour, outlined the historic nature of the settlement, which resolves some of the legal strife following a prior decision by the Supreme Court. The landmark $7.4 billion settlement is the largest to date in the ongoing legal battles with pharmaceutical companies accused of contributing to a national public health crisis. An upcoming bankruptcy court hearing, as mentioned by PBS Newshour, will seek to advance the process, setting the stage for the distribution of settlement funds to affected communities.
The culmination of this legal reckoning brings Louisiana's total allocated funds from opioid settlements to nearly $641 million, combining previous settlements with other drug companies alongside the latest with Purdue Pharma.
